Press releases
Ken Paulus of Prime Therapeutics becomes chairman of PCMA Board of Directors
Paulus honored to take on this role within our industry at this important time
September 15, 2020“I’m honored to take on this role within our industry at this important time,” said Mr. Paulus. “As we continue to deal with a crippling global pandemic, prescription drug access and affordability are central issues. We need to remain committed to putting patients first as we move forward.”
PCMA is the national association representing America’s pharmacy benefit managers (PBMs) which administer prescription drug plans for more than 266 million Americans with health coverage through Fortune 500 companies, health insurers, labor unions, Medicare, Medicaid, and the Federal Employees Health Benefits Program, as well as the Exchanges established by the Affordable Care Act.
“I’d like to thank Alan Lotvin for his leadership and dedication as PCMA’s chairman. He has navigated the association and the industry through a difficult time for our nation. I congratulate Ken on his new role,” said PCMA President & CEO JC Scott. “Our industry will benefit greatly from the diverse experience and expertise that he brings as the next chairman of PCMA.”
Related news
Press releases
May 5, 2022
Prime Therapeutics is acquiring Magellan Rx to advance integrated specialty drug management, accelerating efforts to lower the cost of drugs and improve health outcomes
EAGAN, Minn. – Pharmacy benefit manager Prime Therapeutics LLC (Prime) on May 3…
Press releases
April 11, 2022
ClearStone Solutions selects Prime Therapeutics as pharmacy benefit manager
EAGAN, Minn. – Prime Therapeutics LLC (Prime) announced today that they will begin…
Press releases
February 25, 2022
Prime Therapeutics unveils inaugural diversity, equity and inclusion (DEI) transparency report
EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) today…